Analysts reset Nvidia stock price targets split Dow entry talk
Nvidia CEO sees $1 trillion in value added in 74 days. Shares drop ahead of trading after stock split. Analysts revise targets.
7939 NW 21st St
Miami, Florida
Nvidia CEO sees $1 trillion in value added in 74 days. Shares drop ahead of trading after stock split. Analysts revise targets.
Sesame Workshop's star-studded benefit gala featured Shonda Rhimes, Oprah Winfrey, and more, raising $3 million to support early childhood education.
First GOP presidential debate of 2024 will take place in Milwaukee on Wednesday, without Donald Trump. Candidates' personal wealth also discussed.
Miracle weight loss drugs are set to become more available after the US approves Zepbound, a cheaper competitor to Wegovy.
Pfizer facility in North Carolina damaged by tornado, impact on production unknown.
Pfizer faces penicillin shortage due to surge in syphilis infections.
FDA approves nonprescription oral contraceptive, Opill, expected to hit stores in early 2024.
Ever wondered what's bounding about in the world of Pfizer? Well, you're not alone. We can consistently uncover a plethora of fascinating news content under the topic of Pfizer, spanning diverse areas from cutting-edge medical research to pioneering developments in healthcare.
The most notable recent news undoubtedly revolves around Pfizer’s massive contribution to battling COVID-19. With people worldwide showing eagerness toward vaccination against this deadly virus, aren't we all interested in knowing how Pfizer's vaccines perform? You bet!
Alongside this headline-hitting vaccine development, we could also unearth stories about their latest pharmaceutical innovations and drug approvals. Did you know they are always developing new treatments for conditions such as cancer and heart disease?
No doubt, like me, you'd be curious about what makes them tick operationally too. Under 'Pfizer', there would naturally be updates on any partnership deals within the industry or strategic company moves taken by top management - think board reshuffles or asset acquisitions. A prime example is their $6 billion acquisition deal with Anacor Pharmaceuticals Inc back in 2016 – huge right?
If finances pique your interest (and why wouldn’t they?), corporate earnings reports populated yearly with financial figures detailing profits and losses become important puzzle pieces towards understanding this pharma mogul better.
Finally, socially conscious folks would find fodder concerning ESG Stories (Environment Social Governance) pertaining to how committed Pfizer is toward sustainable corporate practices. Who said big corporations couldn’t go green?
In essence; whether it's breakthroughs at the scientific frontiers or murmurs from Wallstreet trading floors -the discourse around Pfizer is virtually endless! So here’s my question: isn’t it time we dived deeper into that exciting journey together?